As of recently, pharmaceutical manufacturers are seeing increased pricing pressure due to the consolidation of customers in the marketplace. While there is plenty of demand, the supply is more excessive. With that as a challenge, another challenge becomes achieving business while maintaining quality, meeting regulations and staying nimble in a marketplace that’s ever-changing.
What can pharmaceutical manufacturers do about this? Focusing on quality, manufacturing efficiencies, and sustainability in terms of R&D is a start, according to Priyanka Chigurupati, executive director at Granules Pharmaceuticals. “In an ideal scenario, if there is a direct link between manufacturers and end customer, the goal of actually getting product at a certain price to the end customer will be attained,” Chigurupati said.
For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.
Follow us on social media for the latest updates in B2B!